Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors

• المؤلفون الرئيسيون: Xue-lin Zou (مؤلف), Wei-yong Chen (مؤلف), Guang-yan Zhang (مؤلف), Hua Ke (مؤلف), Qiu-hong Yang (مؤلف), Xiao-bo Li (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

In recent years, immune checkpoint inhibitors (ICIs) have become the standard treatment option for tumors. With the widespread application of ICIs, immune-related adverse events (irAEs) have gradually attracted the attention of researchers. Owing to the characteristics of ICIs, irAEs can affect each...